Skip to main content
. 2019 Feb;11(2):573–582. doi: 10.21037/jtd.2018.11.96

Table 1. Demographics and clinical characteristics of patients selected.

Factors No SPC (%) SPC (%) P value
Total 226,374 (93.6) 15,431 (6.4)
Gender 0.009
     Female 104,358 (93.5) 7,281 (6.5)
     Male 122,016 (93.7) 8,150 (6.3)
Race 0.000
     White 180,806 (93.3) 13,054 (6.7)
     Black 27,420 (94.6) 1,554 (5.4)
     Others 18,148 (95.7) 823 (4.3)
Age 0.000
     ≤60 57,272 (95.0) 3,029 (5.0)
     61–70 70,855 (92.6) 5,689 (7.4)
     71–80 67,280 (92.8) 5,239 (7.2)
     >80 30,967 (95.5) 1,474 (4.5)
Differentiation 0.000
     Well 13,196 (88.6) 1,699 (11.4)
     Moderate 48,311 (90.5) 5,076 (9.5)
     Poor 64,400 (93.3) 4,654 (6.7)
     Undifferentiated 3,622 (93.6) 247 (6.4)
     Unknown 96,845 (96.3) 3,755 (3.7)
Histology 0.000
     Squamous 71,872 (93.8) 5,214 (6.2)
     Adenocarcinoma 139,336 (93.8) 9,220 (6.2)
     Others 15,166 (93.8) 997 (6.2)
T-stage 0.000
     T0 967 (96.4) 36 (3.6)
     T1 41,558 (87.9) 5,741 (12.1)
     T2 65,352 (92.1) 5,617 (7.9)
     T3 13,844 (95.0) 731 (5.0)
     T4 82,018 (97.0) 2,555 (3.0)
     Tx 22,635 (96.8) 751 (3.2)
N-stage 0.000
     N0 87,474 (89.7) 10,087 (10.3)
     N1 19,684 (93.2) 1,425 (6.8)
     N2 76,322 (96.5) 2,739 (3.5)
     N3 25,935 (97.4) 696 (2.6)
     Nx 16,959 (97.2) 484 (2.8)
M-stage 0.000
     M0 118,470 (90.4) 12,532 (9.6)
     M1 99,611 (97.5) 2,558 (2.5)
     Mx 8,293 (96.1) 341 (3.9)
Marriage 0.000
     Married 116,431 (93.1) 8,681 (6.9)
     Others 109,943 (94.2) 6,750 (5.8)
Radiation 0.000
     Radiation 88,876 (95.3) 4,377 (4.7)
     Others 137,498 (92.6) 11,054 (7.6)
Chemotherapy 0.000
     Yes 100,570 (94.8) 5,569 (5.2)
     Others 125,804 (92.7) 9,862 (7.3)
Surgical procedure 0.000
     No 166,989 (96.6) 5,894 (3.4)
     Sublobectomy 11,430 (86.2) 1,827 (13.8)
     Lobectomy 42,853 (85.5) 7,272 (14.5)
     Pneumonectomy 3,393 (90.5) 356 (9.5)
     Surgery (the type of operation is unclear.) 537 (91.8) 48 (8.2)
     Unknown 1,172 (97.2) 34 (2.8)
Survival 0.000
     Alive 56,200 (89.9) 6,301 (10.1)
     Dead 170,174 (94.9) 9,130 (5.1)

NSCLC, non-small cell lung cancer; SPC, second primary cancer.